Towards Healthcare
Asthma Treatment Market Size Expand $38.57 Bn by 2034

Asthma Treatment Market New Drug Pipelines & Personalized Medicine

Projections indicate the asthma treatment market will increase from USD 27.61 billion in 2024 to USD 38.57 billion by 2034, experiencing a CAGR of 3.4% over the next 10 years. Asthma treatment focuses on controlling symptoms and preventing attacks. It includes quick-relief inhalers (like albuterol) for sudden symptoms and daily controller medications (such as steroids) to reduce inflammation. Avoiding triggers, staying active, and following a doctor’s plan help manage asthma effectively.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Asthma Treatment Market Assessment

  • Overview
  • Global Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Medication (2021 – 2033)
    • Quick-relief Medication
    • Long-term Control Medication
  • Global Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Inhalers
    • Prefilled Syringes/Vials
    • Others
  • Global Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Adjunct Therapy (2021 – 2033)
    • LAMA (long-acting muscarinic antagonists)
    • LABA (long-acting beta antagonists)
    • Others
  • Global Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
  • Global Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Malaysia
      • Philippines
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of the Middle East & Africa

North America Asthma Treatment Market Assessment

  • Overview
  • North America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Medication (2021 – 2033)
    • Quick-relief Medication
    • Long-term Control Medication
  • North America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Inhalers
    • Prefilled Syringes/Vials
    • Others
  • North America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Adjunct Therapy (2021 – 2033)
    • LAMA (long-acting muscarinic antagonists)
    • LABA (long-acting beta antagonists)
    • Others
  • North America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
  • North America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.S.
    • Canada

Europe Asthma Treatment Market Assessment

  • Overview
  • Europe Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Medication (2021 – 2033)
    • Quick-relief Medication
    • Long-term Control Medication
  • Europe Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Inhalers
    • Prefilled Syringes/Vials
    • Others
  • Europe Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Adjunct Therapy (2021 – 2033)
    • LAMA (long-acting muscarinic antagonists)
    • LABA (long-acting beta antagonists)
    • Others
  • Europe Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
  • Europe Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • U.K.
    • Germany
    • France

Asia-Pacific Asthma Treatment Market Assessment

  • Overview
  • Asia-Pacific Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Medication (2021 – 2033)
    • Quick-relief Medication
    • Long-term Control Medication
  • Asia-Pacific Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Inhalers
    • Prefilled Syringes/Vials
    • Others
  • Asia-Pacific Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Adjunct Therapy (2021 – 2033)
    • LAMA (long-acting muscarinic antagonists)
    • LABA (long-acting beta antagonists)
    • Others
  • Asia-Pacific Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
  • Asia-Pacific Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines

Latin America Asthma Treatment Market Assessment

  • Overview
  • Latin America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Medication (2021 – 2033)
    • Quick-relief Medication
    • Long-term Control Medication
  • Latin America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Inhalers
    • Prefilled Syringes/Vials
    • Others
  • Latin America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Adjunct Therapy (2021 – 2033)
    • LAMA (long-acting muscarinic antagonists)
    • LABA (long-acting beta antagonists)
    • Others
  • Latin America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
  • Latin America Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • Brazil
    • Rest of Latin America

Middle East & Africa (MEA) Asthma Treatment Market Assessment

  • Overview
  • Middle East & Africa (MEA) Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Medication (2021 – 2033)
    • Quick-relief Medication
    • Long-term Control Medication
  • Middle East & Africa (MEA) Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Inhalers
    • Prefilled Syringes/Vials
    • Others
  • Middle East & Africa (MEA) Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Adjunct Therapy (2021 – 2033)
    • LAMA (long-acting muscarinic antagonists)
    • LABA (long-acting beta antagonists)
    • Others
  • Middle East & Africa (MEA) Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
  • Middle East & Africa (MEA) Asthma Treatment Market Size Value (US$) and Volume (Billion Tons), by Country (2021 – 2033)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Company Profiles

  • AstraZeneca
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • Roche Holding AG / Novartis AG
  • Merck & Co., Inc.
  • Koninklijke Philips N.V.
  • Sanofi-Aventis SA
  • MundiPharma

Conclusion & Recommendations

  • Insight Code: 5049
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: February 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of experience specializing in the healthcare sector. His expertise spans various facets of healthcare, including market dynamics, emerging trends, regulatory changes, and technology-driven innovations. With a keen eye for detail and a deep understanding of the global healthcare landscape, Rohan has been instrumental in shaping actionable insights that guide healthcare organizations in making informed, data-driven decisions.

Rohan's extensive experience covers a wide range of healthcare segments, from pharmaceuticals and biotechnology to medical devices and digital health. He has worked on numerous projects that evaluate market potential, assess competitive landscapes, and identify growth opportunities in rapidly evolving sectors in the healthcare industry.

His analytical acumen and ability to synthesize complex data have made him a trusted advisor to healthcare companies, helping them navigate the challenges and opportunities within the healthcare ecosystem. Rohan is particularly passionate about how technology and innovation are reshaping healthcare delivery, and his reports provide valuable insights into the impact of digital transformation on patient care, outcomes, and cost-efficiency.

With a strong track record in healthcare market research, Rohan continues to contribute significantly to the advancement of the industry by delivering data-backed strategies and comprehensive market analysis.

FAQ's

The rising incidence of asthma worldwide, increasing awareness and diagnosis of the condition, advancements in treatment options, and growing healthcare expenditure are key driving factors for the asthma treatment market. Additionally, the development of personalized medicine approaches and technological innovations in asthma management contribute to market growth.

Some emerging trends in the asthma treatment market include the development of biological therapies targeting specific inflammatory pathways, the integration of artificial intelligence and machine learning in asthma management, and the focus on precision medicine approaches. Additionally, there is a growing emphasis on patient-centric care, self-management tools, and patient education to empower individuals with asthma to better manage their condition.

The asthma treatment market is global, with a significant market share held by regions such as North America, Europe, and Asia Pacific. North America, specifically the United States, has a well-established market due to high asthma prevalence, advanced healthcare infrastructure, and significant investment in research and development. Europe also holds a substantial market share, driven by increasing awareness and access to advanced therapies. The Asia Pacific region is witnessing rapid market growth due to a rising incidence of asthma, improving healthcare infrastructure, and increasing investments in healthcare.

World Health Organization, Asthma and Allergy Foundation of America, and U.S. Department of Health & Human Services

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515